Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas

Genes Chromosomes and Cancer

Volumn 36, Issue 2, 2003, Pages 139-150

  Tomioka, Nobumoto ^a,b,c   Kobayashi, Hirofumi ^a   Kageyama, Hajime ^b   Ohira, Miki ^b   Nakamura, Yohko ^b   Sasaki, Fumiaki ^c   Todo, Satoru ^c   Nakagawara, Akira ^b   Kaneko, Yasuhiko ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRC5 GENE; CANCER RISK; CELL POPULATION; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; DIPLOIDY; DISOMY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENETIC HETEROGENEITY; GENETIC RESISTANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; MYCN GENE; NEUROBLASTOMA; NME1 GENE; PLOIDY; PRIORITY JOURNAL; TETRASOMY; TRKA GENE; TUMOR SUPPRESSOR GENE;

ALLELIC IMBALANCE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETIC ANALYSIS; DIPLOIDY; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS; POLYPLOIDY; SURVIVAL ANALYSIS;

EID: 0037299486     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10151     Document Type: Article

References (40)

1. Ambrosini G, Adida C, Alitieri D. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
2. Bourhis J, DeVathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNilly NJ, Lemerle J, Riou G, Benard J. 1991a. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 51:33-36.
3. Bourhis J, Dominici C, McDowell H, Raschella G, Wilson G, Castello MA, Plouvier E, Lemerle J, Riou G, Benard J, Hartmann O. 1991b. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. J Clin Oncol 9:1371-1375.
4. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson ADJ, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954-1961.
5. Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W, Dworniczak BD. 1998. Comparative genomic hybridization and telomerase activity analysis identify two blologically different groups of 4s neuroblastomas. Br J Cancer 77:2223-2229.
6. Brodeur GM, Castleberry RP. 1997. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Pediatric oncology, Third Ed. Philadelphia: J. B. Lippincott, p 761-797.
7. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, Bernardi BD, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477.
8. Caron H, Van Sluis P, Kraker J, Bokkerink J. Egeler M, Laureys G. Slater R, Westerveld A, Voute PA, Versteeg R. 1996. Allelic loss of chromosome 1p as predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334:225-230.
9. Christiansen H, Schestag J, Christiansen NM, Grzeschik K, Lampert F. 1992. Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study. Genes Chromosomes Cancer 5:141-149.
10. Cillo C, Faiella A, Cantile M, Boncinelli E. 1999. Homeobox genes and cancer. Exp Cell Res 248:1-9.
11. Cox DR. 1972. Regression models and life tables. J Roy Stat Soc 187-220.
12. Evans AE, D'Angio GJ, Randolph J. 1971. A proposed staging for children with neuroblastoma. Cancer 27:374-378.
13. Furuta S, Ohira M, Machida T, Hamano S, Nakagawara A. 2000. Analysis of loss of heterozygosity at 16p12-p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors. Med Pediatr Oncol 35:531-533.
14. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM. 1999. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18:4948-4957.
15. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM. 1991. High levels of p19/nm23 protein in neuroblastoma associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345.
16. Inazawa J, Saito H, Ariyama T, Abe T, Nakamura Y. 1993. High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. Genomics 17:153-162.
17. Islam A, Kageyama H, Takada N, Kawamato T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A. 2000. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oneogene 19:617-623.
18. Kaneko Y, Knudson AG. 2000. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 29:89-95.
19. Kaneko Y, Kanda N, Maseki N, Sakurai Ma, Tsuchida Y, Takeda T, Okabe I, Sakurai Mi. 1987. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311-318.
20. Kaneko Y, Kobayashi H, Maseki N, Nakagawara A, Sakurai M. 1999. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting naeuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants, Int J Cancer 80:54-59.
21. Kaplan EL, Meier P. 1958. Nonparametric estimation for incomplete observations. J Am Star Assoc 53:457-481.
22. Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL. 1998. Prognostic significance of age. MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(4S) neuroblastoma: the pediatric oncology group experience: a pediatric oncology group study. J Clin Oncol 16:2007-2017.
23. Kobayashi H, Satake N, Maseki N, Sakashita A, Kaneko Y. 1996. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Br J Haematol 94:105-111.
24. Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW. 1983. Transposition and amplification of oncogene-related sequences in human neuioblastomas. Cell 35:359-367.
25. Kumon K, Kobayashi H, Namiki T, Tsunematsu Y, Miyauchi J, Kikuta A, Horikoshi Y, Komada Y, Hatae Y, Eguchi H, Kaneko Y. 2001. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res 92:854-862.
26. Kushner BH, Gilbert F, Helson L. 1987. Familial neuroblastoma: case reports, literature review, and etiologic considerations. Cancer 57:1887-1893.
27. Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson ADJ, Jackson MS. 2001. Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 19:3080-3090.
28. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM. 1993. Evidence for nm23 RNA overexpression. DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865.
29. Look AT. Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. 1991. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 19:581-591.
30. Meddeb M, Danglot G, Chudoba I, Venuat A, Benard J, Avet-Loiseau H, Vasseur B, Paslier DL, Terrier-Lacombe M, Hartmann O, Bernheim A. 1996. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 17:156-165.
31. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. 1993. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854.
32. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. 1997. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
33. Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A, Shimizu K, Nagahara N, Yamamoto K. 1984. Mass screening for neuroblastoma in infants in Japan. Lancet ii:271-273.
34. Sawaguchi S, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Matsuyama S, Takahashi H, Nakajo T, Hoshi Y, Okabe I, Yokoyama J, Nishihira H, Sasaki S, Sakurai M, Sawada T, Nagahara N, Tsuchida Y. 1990. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. Cancer 66:1879-1887.
35. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U. Michaelis J. 2002. Neuroblastoma screening at one year of age. N Engl J Med 346:1047-1053.
36. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y. 1994. There may be two tumor suppressor genes on chromosome arm lp closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10:30-39.
37. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, Paepe AD, Speleman F. 1998. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23:141-152.
38. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL. 1988. Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532.
39. Weiss JM, Guo C, Shusterman S, Hii G, Mirensky TL, White PS, Hogarty MD, Rebbeck TR, Teare D, Urbanek M, Brodeur GM, Maris JM. 2000. Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Med Pediatr Oncol 35:526-530.
40. Woods WG, Gao R, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B. 2002. Screening of infants and mortality due to neoroblastoma. N Engl J Med 346:1041-1046.